Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (L... von Margolis, David A, Dr, Brinson, Cynthia C, MD, Smith, Graham H R, MD, de Vente, Jerome, MD, Hagins, Debbie P, MD, Eron, Joseph J, Prof, Griffith, Sandy K, PharmD, Clair, Marty H St, BS, Stevens, Marita C, MD, Williams, Peter E, PhD, Ford, Susan L, PharmD, Stancil, Britt S, BS, Bomar, Melinda M, BS, Hudson, Krischan J, PhD, Smith, Kimberly Y, MD, Spreen, William R, PharmD

Volltext

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy von Mills, Anthony, Richmond, Gary J., Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Margolis, David A., Sutton, Kenneth C., Wilches, Viviana, Hatch, Sarah, Roberts, Jeremy, McCoig, Cynthia, Garris, Cindy, Vandermeulen, Kati, Spreen, William R.

Volltext

Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: a qualitative study von Walker, Daisy, Moucheraud, Corrina, Butler, Derrick, de Vente, Jerome, Tangonan, Kevin, Shoptaw, Steven, Currier, Judith S, Gladstein, Jay, Hoffman, Risa

Volltext

Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results von Mills, Anthony, Richmond, Gary J., Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, de Vente, Jerome, Margolis, David A., Sutton, Kenneth C., Wilches, Viviana, Hatch, Sarah, Roberts, Jeremy, McCoig, Cynthia, Garris, Cindy, Vandermeulen, Kati, Spreen, William R.

Volltext

1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants von Towner, William, DeJesus, Edwin, Schrader, Shannon, De Vente, Jerome, McGary, Colleen, Zogheib, Mohammed, Weinheimer, Steven, Mesquita, Pedro

Volltext

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study von Sutton, Kenneth C, De Vente, Jerome, Leblanc, Roger, Dejesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt S, Vandermeulen, Kati, Spreen, William R

Volltext

116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results... von Mills, Anthony, Richmond, Gary J, Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Andany, Nisha, Margolis, David, Sutton, Kenneth, Wilches, Viviana, Roberts, Jeremy, McCoig, Cynthia C, Vandermeulen, Kati, Spreen, William

Volltext

2840. Long-term Efficacy, Safety, and Durability of CAB and RPV as Two Drug Oral Maintenance Therapy: LATTE Week 312 Results von Margolis, David, Sutton, Kenneth, De Vente, Jerome, LeBlanc, Roger, DeJesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt, Williams, Peter, Spreen, William

Volltext

Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center von Rice, Louis B., Eckstein, Elizabeth C., DeVente, Jerome, Shlaes, David M.

Volltext

Acute suppurative thyroiditis and necrosis of the thyroid gland: A rare endocrine manifestation of acquired immunodeficiency syndrome von Golshan, Mehra M, McHenry, Christopher R, de Vente, Jerome, Kalajyian, Robert C, Hsu, Rebecca M, Tomashefski, Joseph F

Volltext